Revmoxicam (meloxicam) tablets 7.5 mg. №20

$11.00

Short- term symptomatic treatment of acute attacks of rheumatoid arthritis and ankylosing spondylitis, when oral and rectal routes of administration can not be applied.

Category: Manufacturer: Ukraine

Description

Composition and form of release
The active ingredient is meloxicam.
Release form – tablets.
One tablet contains 7,5 mg of meloxicam.

Pharmacological properties
Non-steroidal anti-inflammatory (NSAID) and antirheumatic pharmaceuticals.
It has analgesic (pain relieving), antiphlogistic (anti-inflammatory) and antipyretic (antipyretic) effects.

Indications
Revmoxicam tablets are used for the symptomatic treatment of pain syndrome with:

  • ankylosing spondylitis;
  • arthrosis;
  • osteoarthritis;
  • degenerative joint diseases;
  • rheumatoid arthritis.

Contraindications
Revmoxicam tablets are prohibited in case of hypersensitivity to them or to other NSAIDs.
Also contraindications to the use of Revmoxicam are:

  • blood clotting disorders, bleeding;
  • the presence of ulcers / perforation in the digestive tract;
  • severe liver failure;
  • active Crohn’s disease / ulcerative colitis;
  • severe renal failure without hemodialysis;
  • children up to age twelve;
  • severe uncontrolled heart failure.

Application during pregnancy and lactation
It is forbidden to use Revmoxicam tablets during these periods.

Method of administration and dosage
Revmoxicam tablets are taken with meals.
In osteoarthritis, the dose of Revmoxicam is 7.5 mg / day; if necessary, the dose is increased to 15 mg / day.
In rheumatoid arthritis and ankylosing spondylitis, the drug is used at 15 mg / day; if a positive therapeutic effect is obtained, the dose can be reduced to 7.5 mg / day.
The maximum dose of Revmoxicam for an adult is 15 mg / day.
The maximum dose for a child over twelve years old is 0.25 mg / kg of body weight / day.
With the combined use of Revmoxicam (tablets and suppositories), the total daily dose cannot exceed 15 mg.
The duration of therapy is set by the treating doctor individually.

Overdose
For acute drug overdose Revmoxicam is characterized by: drowsiness, abdominal pain, nausea, lethargy, vomiting. Bleeding from the digestive tract is also possible. In severe poisoning, hypertension, liver dysfunction, acute renal failure, cardiac arrest, coma may occur.
Treatment in case of an overdose with Revmoxicam tablets provides for the withdrawal of the drug, gastric lavage and symptomatic treatment. There is no specific antidote.

Side effects
Side effects that may occur during the use of the pharmaceutical drug Revmoxicam include the following: stomatitis, dizziness, dyspepsia, palpitations, esophagitis, flatulence, headache, edema, tinnitus, drowsiness, mood changes, conjunctivitis, confusion, visual disturbances, nausea, colitis, increased blood pressure, hot flashes, gastritis, disorientation, gastroduodenal ulcer, acute renal failure, vomiting, photosensitivity, liver dysfunction, abdominal pain, pruritus, belching, gastrointestinal perforation, constipation / diarrhea, skin rashes, bleeding from the digestive tract.
Changes in the blood picture may also occur – thrombocytopenia (a decrease in the number of platelets), leukopenia (a decrease in the number of white blood cells), anemia (a decrease in the number of red blood cells).
Possible anaphylactic reactions, polymorphic erythema, Stevens-Johnson syndrome, angioedema, urticaria.
Patients who are allergic to NSAIDs may develop an asthma attack.

Storage conditions and periods
The pharmaceutical preparation Revmoxicam should be stored in a place protected from light, at temperatures below + 25 ° C.
The shelf life of Revmoxicam tablets is three years.